Implementation of pre‐seasonal sublingual immunotherapy with a five‐grass pollen tablet during optimal dosage assessment
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: Background The optimal dose (300IR) of a five‐grass pollen sublingual immunotherapy tablet in terms of efficacy was previously demonstrated from the first pollen season. Objective Here, we aim to confirm whether this dose remained optimal during the peak of the pollen season by assessing the efficacy and quality of life data. Methods A total of 628 subjects with grass pollen rhinoconjunctivitis were randomized in a double‐blind, placebo‐controlled, multi‐centre, pan‐European trial. Subjects received once‐daily tablets (Stallergenes, Antony, France) of 100IR, 300IR, 500IR or placebo, starting 4 months before and throughout the 2005 grass pollen season. The pollen season was defined as the first day of 3 consecutive days with a grass pollen count above 30 grains/m 3 of air, recorded using Hirst‐type volumetric pollen traps, to the last day before 3 consecutive days with a pollen count below 30 grains/m 3. Results The grass pollen season lasted an average of 30 days, with a peak of 12 days. The mean treatment duration before the grass pollen season was similar in the four treatment groups (121.4±31.1 to 128.6±15.4 days in the safety population). Both the 300IR and 500IR groups had highly significant improvements in Rhinoconjunctivitis Total Symptom Score (RTSS) vs. placebo at the peak pollen season (P=0.0005 and 0.0014, respectively), which agreed with improvements in RTSS in the primary evaluations. The average RTSS scores were slightly elevated during the peak pollen season in all treatment groups. The overall Rhinoconjunctivitis Quality of Life Questionnaire score confirmed the optimal dosage 300IR at peak (P<0.0001) and at the end (P 0.0031) of the pollen season. All doses were well tolerated. Conclusion At the peak pollen season, the efficacy and quality of life data for both 300IR and 500IR groups was significantly improved vs. the placebo group. These results confirm the conclusions of the primary evaluations and validate the use of 300IR tablets for clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergenic pollen and pollen allergy in Europe.
D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi‐Maesano, I., Behrendt, H., Liccardi, G., Popov, T., & Van Cauwenberge, P. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01393.x · Cited by 1,342
Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis*
Wilson, D. R., Torres Lima, M., & Durham, S. R. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00699.x · Cited by 660
Cited by
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Horak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Devillier, P., Montagut, A., Mélac, M., Galvain, S., Jean-Alphonse, S., Van Overtvelt, L., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.006 · Cited by 175
“The pollen season tends to vary from year to year because of fluctuations in climatic factors, but the maximum atmospheric concentration of grass pollen usually occurs 1 to 2 months after the start of the main flowering season.(4,5) The current study assessed the efficacy and onset of action of 5-grass-pollen tablets…”
BackgroundSelf-citationHowarth, P., Malling, H. ‐., Molimard, M., & Devillier, P. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02759.x · Cited by 61
Calderon, M. A., Bernstein, D. I., Blaiss, M., Andersen, J. S., & Nolte, H. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12331 · Cited by 28
Serrano, E., Wahn, H. U., Didier, A., & Bachert, C. (2014) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2014.28.4112 · Cited by 7
Self-citation
Metadata
- Authors
- Horak, F., Jaeger, S., Worm, M., Melac, M., & Didier, A.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 2009-01-28
- Volume
- 39
- Issue
- 3
- Pages
- 394-400
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W2129356951
- Cited by
- 35
- References
- 2
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implementation of pre‐seasonal sublingual immunotherapy with a five‐grass pollen tablet during optimal dosage assessment. https://app.cochat.ai/papers/10.1111/j.1365-2222.2008.03153.x
- The paper
- Horak, F., Jaeger, S., Worm, M., Melac, M., & Didier, A. (2009). Implementation of pre‐seasonal sublingual immunotherapy with a five‐grass pollen tablet during optimal dosage assessment. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2008.03153.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.